Literature DB >> 2723588

Radioimmunoassay of human pepsinogen A and pepsinogen C.

I Biemond1, J B Jansen, L F Crobach, J Kreuning, C B Lamers.   

Abstract

We describe the development of radioimmunoassays to measure both human pepsinogen A and pepsinogen C concentrations in serum. The antibodies were raised in goats by immunization with purified pepsinogen A or C. The affinity constants of the respective antibodies were 20.10(10) l/mol and 7.10(10) l/mol. Pepsinogens A and C were labeled with Na 125I by the chloramine T method. The binding between labels and antibodies was inhibited by 0.50 at 0.82 ng pepsinogen A per tube and 2.1 ng pepsinogen C per tube. The detection limits of the assay of pepsinogen A and C were 0.12 microgram/l and 1.8 micrograms/l, respectively. Pepsinogen A and C were purified and added to a patient serum, showing a good recovery in the radioimmunoassays. Serial dilution of another patient serum, which contained a high concentration of both antigens, showed curves parallel to the standard curves. The intra- and interassay variations of these radioimmunoassays were evaluated. The intra-assay coefficients of variation for pepsinogen A were found to vary from 0.03 to 0.102 at concentrations in serum in the normal range, while the inter-assay coefficient of variation ranged from 0.118 to 0.194 at the same concentrations in serum. For the pepsinogen C radioimmunoassay we found intra-assay coefficients of variation between 0.126 and 0.147 at concentrations in serum in the normal range, while the inter-assay coefficient of variation ranged from 0.174 to 0.325 for the same sera. In 201 blood donors we found a mean serum concentration of pepsinogen A of 59 micrograms/l and a mean serum concentration of pepsinogen C of 15 micrograms/l. There was a significant relationship between these values (r = 0.779, p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723588     DOI: 10.1515/cclm.1989.27.1.19

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  12 in total

1.  Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens.

Authors:  L C Baak; J B Jansen; I Biemond; C B Lamers
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone.

Authors:  T Iwao; A Toyonaga; M Ikegami; H Shigemori; K Oho; M Sumino; K Tanikawa
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

3.  Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.

Authors:  I Biemond; L F Crobach; J B Jansen; C B Lamers
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors.

Authors:  R A Veenendaal; I Biemond; A S Peña; W van Duijn; J Kreuning; C B Lamers
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

5.  Serum pepsinogens after interruption of long-term maintenance therapy with omeprazole in patients with reflux esophagitis.

Authors:  I Biemond; E C Klinkenberg-Knol; C B Lamers; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Serological parameters in assessment of degree of gastritis in healthy volunteers.

Authors:  J Kreuning; J Lindeman; I Biemond; C B Lamers
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

7.  Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man.

Authors:  J L Meijer; J B Jansen; L F Crobach; I Biemond; C B Lamers
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

8.  Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.

Authors:  R J Schlemper; S D van der Werf; J P Vandenbroucke; I Biemond; C B Lamers
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

9.  Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use.

Authors:  M Janssen; B A Dijkmans; J P Vandenbroucke; I Biemond; C B Lamers
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

10.  Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers.

Authors:  I Biemond; L F Crobach; J B Jansen; C B Lamers
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.